Planned Parenthood
Planned Parenthood was paid $9.76M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 18% of everything it billed.
BAKERSFIELD, CA 93301
Next to other Community Health Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,124 | $1.52M | |
| 2019 | 27,487 | $1.17M | |
| 2020 | 17,693 | $968K | |
| 2021 | 27,972 | $1.73M | |
| 2022 | 21,806 | $1.30M | |
| 2023 | 30,358 | $1.83M | |
| 2024incomplete | 21,048 | $1.24M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 18% | 1,691 | 1,687 | $1.80M |
| J3490 | Unclassified drugs | 16% | 35,809 | 28,783 | $1.52M |
| S4993 | Contraceptive pills for birth control | 8.5% | 7,851 | 7,530 | $828K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.1% | 19,950 | 18,969 | $596K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.7% | 6,756 | 6,516 | $555K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 5.4% | 1,304 | 1,299 | $526K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 3,684 | 3,608 | $442K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.1% | 3,888 | 3,874 | $397K |
| 11981 | 3.9% | 1,572 | 1,568 | $383K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 5,206 | 5,065 | $352K |
| 87806 | 3.4% | 13,270 | 11,967 | $333K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 2.7% | 312 | 308 | $259K |
41 more codes
| A4267 | Contraceptive supply, condom, male, each | 2.5% | 21,869 | $247K |
| 99203 | Doctor's office visit, new patient (routine) | 2.3% | 1,405 | $223K |
| 99201 | 2.0% | 2,323 | $196K | |
| 58300 | 1.4% | 1,207 | $132K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 713 | $116K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 3,663 | $110K |
| 11976 | <1% | 1,236 | $76K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 1,276 | $76K |
| 59840 | <1% | 502 | $70K | |
| 99402 | <1% | 2,117 | $67K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 52 | $57K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 54 | $54K |
| 11982 | <1% | 816 | $51K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,942 | $37K |
| 99401 | <1% | 1,883 | $36K | |
| 81025 | <1% | 10,510 | $33K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 721 | $30K |
| S5000 | Prescription drug, generic | <1% | 2,464 | $20K |
| 99000 | <1% | 8,060 | $20K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 58 | $20K |
| 58301 | <1% | 514 | $19K | |
| 99403 | <1% | 353 | $16K | |
| 83986 | <1% | 4,823 | $14K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 3,721 | $14K |
| 99070 | <1% | 1,540 | $7K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,067 | $5K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 1,412 | $5K |
| 0270 | <1% | 512 | $4K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 299 | $4K |
| 99152 | <1% | 77 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 340 | $2K |
| 85018 | <1% | 638 | $1K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 75 | $899.58 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 24 | $748.08 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 24 | $745.68 |
| 81002 | <1% | 375 | $725.43 | |
| Q3014 | Telehealth originating site facility fee | <1% | 63 | $706.56 |
| 86901 | <1% | 232 | $407.91 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 78 | $248.48 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 78 | $139.36 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 79 | $135.96 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.